Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis

Dig Liver Dis. 2020 Jan;52(1):121-123. doi: 10.1016/j.dld.2019.09.001. Epub 2019 Oct 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Brain Diseases*
  • Galectin 3
  • Glomerular Filtration Rate
  • Helicobacter Infections*
  • Helicobacter pylori*
  • Humans
  • Liver Cirrhosis

Substances

  • Galectin 3